Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Artiva Biotherapeutics, Inc. Common Stock Financials Banner

Artiva Biotherapeutics, Inc. Common Stock Financials

ARTV Stock Analysis

Page title

Section title

ARTV Income Statement Key Metrics

  • Revenue(TTM)1.24 M
  • Gross Profit(TTM)1.24 M
  • EBITDA(TTM)-63.47 M
  • Net Income(TTM)-63.54 M
  • EPS Diluted(TTM)-3.6100000000000003

Decode ARTV's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

ARTV earnings and revenue history

ARTV Return on Equity

See how efficiently ARTV generates profit for it's shareholders.

0%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity Growth

ARTV's Return on Equity has shown poor growth over the past 10 years, increasing by only -100%.

ARTV Revenue Growth

See how ARTV has grown it's revenue over the past 10 years.


Revenue Growth

ARTV's revenue has grown significantly over the past 10 years, increasing by over 0%.

ARTV FY, 2023 Revenue Breakdown

See how ARTV converts it's revenue into profit.

ARTV Balance Sheet Health

ARTV Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

ARTV financial position analysis

Short Term Liabilities

ARTV's short term assets($80M) can safely cover it's short term liabilities($12M).

Long Term Liabilities

ARTV's short term assets($80M) cannot safely cover it's long term liabilities($255M).

ARTV Debt to Equity